Literature DB >> 19149995

Accessories to the crime: recent advances in HIV accessory protein biology.

Thomas Gramberg, Nicole Sunseri, Nathaniel R Landau.   

Abstract

Recent advances in understanding the roles of the lentiviral accessory proteins have provided fascinating insight into the molecular biology of the virus and uncovered previously unappreciated innate immune mechanisms by which the host defends itself. HIV-1 and other lentiviruses have developed accessory proteins that counterattack the antiviral defenses in a sort of evolutionary battle. The virus is remarkably adept at co-opting cellular degradative pathways to destroy the protective proteins. This review focuses on recent advances in understanding three of the accessory proteins-virion infectivity factor (Vif), viral protein R (Vpr), and viral protein U (Vpu)-that target different restriction factors to ensure virus replication. These proteins may provide promising targets for the development of novel classes of antiretroviral drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149995      PMCID: PMC4696859          DOI: 10.1007/s11904-009-0006-z

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  50 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

3.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

4.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

5.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

6.  HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.

Authors:  Bärbel Schröfelbauer; Yoshiyuki Hakata; Nathaniel R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

7.  Molecular cloning of an apolipoprotein B messenger RNA editing protein.

Authors:  B Teng; C F Burant; N O Davidson
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

8.  HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

Authors:  Jean-Philippe Belzile; Ghislaine Duisit; Nicole Rougeau; Johanne Mercier; Andrés Finzi; Eric A Cohen
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

9.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

10.  Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.

Authors:  Natalia Sharova; Yuanfei Wu; Xiaonan Zhu; Ruzena Stranska; Rajnish Kaushik; Mark Sharkey; Mario Stevenson
Journal:  PLoS Pathog       Date:  2008-05-02       Impact factor: 6.823

View more
  9 in total

1.  Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.

Authors:  Rebecca D Powell; Paul J Holland; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  Nuclear RNA export and packaging functions of HIV-1 Rev revisited.

Authors:  Maik Blissenbach; Bastian Grewe; Bianca Hoffmann; Sabine Brandt; Klaus Uberla
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

3.  Antisense transcription in gammaretroviruses as a mechanism of insertional activation of host genes.

Authors:  Mads Heilskov Rasmussen; Borja Ballarín-González; Jinghua Liu; Louise Berkhoudt Lassen; Annette Füchtbauer; Ernst-Martin Füchtbauer; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

4.  Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain.

Authors:  Andreas Hinz; Nolwenn Miguet; Ganesh Natrajan; Yoshiko Usami; Hikaru Yamanaka; Patricia Renesto; Bettina Hartlieb; Andrew A McCarthy; Jean-Pierre Simorre; Heinrich Göttlinger; Winfried Weissenhorn
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

5.  Clinical implications of new findings in HIV basic research.

Authors:  Manish Sagar
Journal:  HIV Ther       Date:  2009-07-01

6.  Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

Authors:  Devi SenGupta; Ravi Tandon; Raphaella G S Vieira; Lishomwa C Ndhlovu; Rachel Lown-Hecht; Christopher E Ormsby; Liyen Loh; R Brad Jones; Keith E Garrison; Jeffrey N Martin; Vanessa A York; Gerald Spotts; Gustavo Reyes-Terán; Mario A Ostrowski; Frederick M Hecht; Steven G Deeks; Douglas F Nixon
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

Review 7.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 8.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

9.  Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy.

Authors:  Iraj Hosseini; Feilim Mac Gabhann
Journal:  PLoS Comput Biol       Date:  2012-02-09       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.